Author/Authors :
Kochiadakis، نويسنده , , George E. and Igoumenidis، نويسنده , , Nikos E. and Hamilos، نويسنده , , Michail E. and Tzerakis، نويسنده , , Panagiotis G. and Klapsinos، نويسنده , , Nikos C. and Chlouverakis، نويسنده , , Gregory I. and Vardas، نويسنده , , Panos E.، نويسنده ,
Abstract :
This prospective, randomized, single-blinded, placebo-controlled study compared the efficacy and safety of sotalol and propafenone when used for long-term prevention of atrial fibrillation. For the long-term maintenance of normal sinus rhythm, propafenone seems to be more effective than sotalol.